Covi-Pantel . NZ Trader Release, page-13

world Cov19 Dash board
https://ncov2019.live/
If you click the first row, you can change to alphabetical countries,,

W,H,O dashboard https://covid19.who.int/

FDA has has also relaxed Trialing Criteria for Repurosing Drugs with High Safety Profile under Cov Emergency Measures.

We have a good understanding of its safety, and the safety evaluation of new drugs takes a long time," said Professor Lewin, who is the lead author on the Australian Rapid Research Information Forum's report on the most promising therapeutics for Covid-19.

That means for a repurposed drug, if you already have data on safety, you can skip phases of the clinical trials process. So instead of having to do phase I clinical trials you can go straight to either phase II, or in some cases phase III or a hybrid phase II and III.

I would have thought Monepantel would fall under that Criteria ??